Succipro
1 known investors
Develops first-in-class therapeutics targeting the succinate-metabolic-inflammatory axis for inflammatory and metabolic diseases.
1 known investors
Develops first-in-class therapeutics targeting the succinate-metabolic-inflammatory axis for inflammatory and metabolic diseases.